Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 186Head & Neck 28Gastrointestinal 27Breast 24CNS 21Genitourinary 18Sarcoma 11Other solid neoplasm 8Tumor-Agnostic 6Gynecologic 6Endocrine 4Dermatologic 3Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Rituximab 1401Cyclophosphamide 1305Vincristine 668Doxorubicin 587Etoposide 527Prednisone 510Cytarabine 486fludarabine 469Methotrexate 445Dexamethasone 413fludarabine phosphate 400Lenalidomide 356Filgrastim 343Bendamustine Hydrochloride 282Radiotherapy 267venetoclax 260ibrutinib 258obinutuzumab 235Peripheral Blood Stem Cell Transplantation 234Melphalan 230Granulocyte Colony-Stimulating Factor 215Bortezomib 204Gemcitabine 202Busulfan 188Whole-Body Irradiation 187Mycophenolic Acid 175Tacrolimus 165Specimen Handling 162Magnetic Resonance Spectroscopy 155Calcium Dobesilate 150

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gefitinib × Lymphoid × Clear all
NCT01602289 2015-06-08

A Study of LY2875358 in Japanese Participants With Advanced Cancer

Eli Lilly and Company

Phase 1 Completed
17 enrolled
LymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡